1994P Carboplatin, etoposide, bevacizumab, and atezolizumab in patients with extensive-stage SCLC – GOIRC-01-2019 CeLEBrATE ML41241 trial

Autor: Rihawi, K., Lamberti, G., Riccardi, F., Mazzoni, F., Follador, A., Bonetti, A., Giardina, D., Genova, C., Bertolini, F., Frassoldati, A., Brighenti, M., Colantonio, I., Pasello, G., Ficorella, C., Cinieri, S., Tiseo, M., Andrini, E., Tognetto, M., Boni, L., Ardizzoni, A.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1063-S1064
Databáze: ScienceDirect